Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Arginine 52 and Histidine 54 Located in a Conserved Amino-Terminal Hydrophobic Region (LX2-R52-G-H54-X3-V-L) Are Important Amino Acids for the Functional and Structural Integrity of the Human Liver UDP-Glucuronosyltransferase UGT1*6

Claire Senay, Mohamed Ouzzine, Eric Battaglia, Dorothy Pless, Virginie Cano, Brian Burchell, Anna Radominska, Jacques Magdalou and Sylvie Fournel-Gigleux
Molecular Pharmacology March 1997, 51 (3) 406-413;
Claire Senay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Ouzzine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Battaglia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorothy Pless
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginie Cano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Burchell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Radominska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Magdalou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Fournel-Gigleux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The hepatic UDP-glucuronosyltransferase UGT1*6 is actively involved in the glucuronidation of short and planar phenols in humans. Based on the irreversible inhibition of the enzyme on chemical modification by 2,3-butanedione and diethyl pyrocarbonate, the roles of His54 and Arg52 were investigated by oligonucleotide site-directed mutagenesis. These amino acids belong to a consensus sequence LX2-R52-G-H54-X3-V-L located in a conserved hydrophobic region of the variable amino-terminal domain of UGT. Arg52 was replaced by alanine (mutant R52A), and His54 was replaced by alanine or glutamine (mutants H54A and H54Q). The immunological and catalytic properties of UGT1*6 and mutants were examined after stable expression in V79 cell lines. Immunoblots and immunoprecipitation studies revealed that the mutant and UGT1*6 proteins were expressed in the microsomal membranes in similar amounts. However, replacement of His54 by glutamine led to a complete loss of activity toward 4-methylumbelliferone, and theVmax value was decreased 4–5-fold in the mutants R52A and H54A compared with the wild-type enzyme. The dissociation constants that characterize the binding of 4-methylumbelliferone and UDP-glucuronic acid to UGT1*6 were not greatly affected by the mutations. Interestingly, H54Q was not recognized by specific antibodies to the amino-terminal portion of UGT1*6, thereby indicating that this amino acid was critical to antibody recognition. In contrast, the mutants R52A and H54A could not be differentiated from the wild-type protein by pH optimum or thermal denaturation. Furthermore, these mutants were still sensitive to irreversible inhibition by diethyl pyrocarbonate and 2,3-butanedione, with second-order inactivation constant values similar to those obtained for UGT1*6. Altogether, the strict conservation of His54 and Arg52 and the mutational analysis of these residues suggest that these amino acids in the hydrophobic amino-terminal consensus sequence LX2-R52-G-H54-X3-V-L are important for the function and the structure required for optimal catalytic efficiency of UGT1*6.

Footnotes

  • Send reprint requests to: Dr. S. Fournel-Gigleux, URA Centre Nationale de Recherche Scientifique 1288, Faculty of Medicine, 54500 Vandoeuvre-lès-Nancy, France. E-mail:sfg{at}pharmaco-med.u-nancy.fr

  • ↵1 Current affiliation: Unité de Recherche Associé au Centre National de Recherche Scientifique 1288, Faculty of Medicine, 54500 Vandoeuvre-lès-Nancy, France.

  • ↵2 Current affiliation: Department of Biochemistry, University of Edinburgh, Edinburgh, EH8 9XD, UK.

  • This work was supported by the Région Lorraine, by the Institut Fédératif de Recherche “Protéines,” by the Ministère de l’Education Nationale, and by National Institutes of Health Grant DK49715. This work is in partial fulfillment of the doctoral thesis of C.S. S.F.G. was the recipient of an INSERM-MRC senior research fellowship.

  • Abbreviations:
    UGT
    UDP-glucuronosyltransferase
    4-MU
    4-methylumbelliferone
    DMEM
    Dulbecco’s modified Eagle’s minimum
    SDS
    sodium dodecyl sulfate
    PCR
    polymerase chain reaction
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    • Received July 18, 1996.
    • Accepted November 25, 1996.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 51, Issue 3
1 Mar 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Arginine 52 and Histidine 54 Located in a Conserved Amino-Terminal Hydrophobic Region (LX2-R52-G-H54-X3-V-L) Are Important Amino Acids for the Functional and Structural Integrity of the Human Liver UDP-Glucuronosyltransferase UGT1*6
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Arginine 52 and Histidine 54 Located in a Conserved Amino-Terminal Hydrophobic Region (LX2-R52-G-H54-X3-V-L) Are Important Amino Acids for the Functional and Structural Integrity of the Human Liver UDP-Glucuronosyltransferase UGT1*6

Claire Senay, Mohamed Ouzzine, Eric Battaglia, Dorothy Pless, Virginie Cano, Brian Burchell, Anna Radominska, Jacques Magdalou and Sylvie Fournel-Gigleux
Molecular Pharmacology March 1, 1997, 51 (3) 406-413;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Arginine 52 and Histidine 54 Located in a Conserved Amino-Terminal Hydrophobic Region (LX2-R52-G-H54-X3-V-L) Are Important Amino Acids for the Functional and Structural Integrity of the Human Liver UDP-Glucuronosyltransferase UGT1*6

Claire Senay, Mohamed Ouzzine, Eric Battaglia, Dorothy Pless, Virginie Cano, Brian Burchell, Anna Radominska, Jacques Magdalou and Sylvie Fournel-Gigleux
Molecular Pharmacology March 1, 1997, 51 (3) 406-413;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • LYN Kinase and Tyrosine Kinase Inhibitors Regulate OATP1B3
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics